XML 81 R71.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION (Details Narrative)
3 Months Ended 9 Months Ended
Dec. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
Dec. 31, 2016
CNY (¥)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Oct. 21, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
May 05, 2019
Oct. 26, 2017
USD ($)
Oct. 26, 2017
CNY (¥)
Dec. 12, 2016
Business Acquisition [Line Items]                          
Goodwill       $ 6,574,743   $ 6,574,743            
Business combination acquisition related costs                  
Net sales       22,331 22,331            
Net income (loss)       (2,668,533) (2,892,584) (7,878,128) (20,008,627)            
Amortization expense of intangible       317,091   317,091              
Tianjin Tajite [Member]                          
Business Acquisition [Line Items]                          
Transferredship of equity percentage                   77.40%     51.00%
Business acquisition consideration amount   $ 2,100,000 ¥ 14,000,000                    
Goodwill                     $ 2,100,000 ¥ 14,010,195  
Transferredship of equity percentage                   26.40%      
Guangyuan Forest Development Co Ltd [Member]                          
Business Acquisition [Line Items]                          
Net income (loss)       22,353 $ 71,250 97,487 $ 694,051            
Changzhou Biowin Pharmaceutical Co Ltd [Member]                          
Business Acquisition [Line Items]                          
Transferredship of equity percentage 51.00%             51.00%          
Business acquisition consideration amount $ 12,097,000                        
Goodwill       6,574,743   6,574,743              
Net sales       231,513   231,513              
Net income (loss)       $ 123,390   $ 123,390              
Cash $ 9,000,000.0             $ 9,000,000.0          
Shares, Issued | shares 3,260,000             3,260,000          
Business Acquisition, Share Price | $ / shares $ 0.001